These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 11554436)

  • 1. Disposition of amiodarone in rats after single and multiple intraperitoneal doses.
    Najjar TA
    Eur J Drug Metab Pharmacokinet; 2001; 26(1-2):65-9. PubMed ID: 11554436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disposition of amiodarone in rats after single and multiple intra-peritoneal doses.
    Najjar TA
    Eur J Drug Metab Pharmacokinet; 2000; 25(3-4):199-203. PubMed ID: 11420890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population pharmacokinetics of long-term oral amiodarone therapy.
    Pollak PT; Bouillon T; Shafer SL
    Clin Pharmacol Ther; 2000 Jun; 67(6):642-52. PubMed ID: 10872646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of the pharmacokinetics and bioavailability of intravenously and orally administered amiodarone in horses.
    De Clercq D; Baert K; Croubels S; van Loon G; Maes A; Tavernier R; Deprez P; De Backer P
    Am J Vet Res; 2006 Mar; 67(3):448-54. PubMed ID: 16506906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and body distribution of amiodarone and desethylamiodarone in rats after oral administration.
    Plomp TA; Wiersinga WM; Van Rossum JM; Maes RA
    In Vivo; 1987; 1(5):265-79. PubMed ID: 2979794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The pharmacokinetics of dronedarone in normolipidemic and hyperlipidemic rats.
    Jardan YA; Brocks DR
    Biopharm Drug Dispos; 2016 Sep; 37(6):345-51. PubMed ID: 27194397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disposition of amiodarone and its proximate metabolite, desethylamiodarone, in the dog for oral administration of single-dose and short-term drug regimens.
    Brien JF; Jimmo S; Brennan FJ; Armstrong PW; Abdollah H
    Drug Metab Dispos; 1990; 18(6):846-51. PubMed ID: 1981527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myocardial amiodarone concentrations after short- and long-term treatment in patients with end-stage heart failure.
    Candinas R; Frielingsdorf J; Ha HR; Carrel T; Turina M; Follath F
    Eur J Clin Pharmacol; 1998 Jan; 53(5):331-6. PubMed ID: 9516032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of CYP1A induction on amiodarone disposition in the rat.
    Elsherbiny ME; Brocks DR
    J Pharm Sci; 2010 Jan; 99(1):539-48. PubMed ID: 19718765
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics of intravenous amiodarone and its electrocardiographic effects on healthy Japanese subjects.
    Shiga T; Tanaka T; Irie S; Hagiwara N; Kasanuki H
    Heart Vessels; 2011 May; 26(3):274-81. PubMed ID: 21052689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distribution of amiodarone in heart tissues following intrapericardial administration.
    Darsinos JT; Karli JN; Samouilidou EC; Krumbholz B; Pistevos AC; Levis GM
    Int J Clin Pharmacol Ther; 1999 Jun; 37(6):301-6. PubMed ID: 10395122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of desethylamiodarone in the rat after its administration as the preformed metabolite, and after administration of amiodarone.
    Shayeganpour A; Hamdy DA; Brocks DR
    Biopharm Drug Dispos; 2008 Apr; 29(3):159-66. PubMed ID: 18161885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Physiologically Based Pharmacokinetic Model of Amiodarone and its Metabolite Desethylamiodarone in Rats: Pooled Analysis of Published Data.
    Lu JT; Cai Y; Chen F; Jia WW; Hu ZY; Zhao YS
    Eur J Drug Metab Pharmacokinet; 2016 Dec; 41(6):689-703. PubMed ID: 26254911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population modelling to describe pharmacokinetics of amiodarone in rats: relevance of plasma protein and tissue depot binding.
    Campos Moreno E; Merino Sanjuán M; Merino V; Nácher A; Martín Algarra RV; Casabó VG
    Eur J Pharm Sci; 2007 Feb; 30(2):190-7. PubMed ID: 17218087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of experimental hyperlipidemia on the distribution and metabolism of amiodarone in rat.
    Shayeganpour A; Korashy H; Patel JP; El-Kadi AO; Brocks DR
    Int J Pharm; 2008 Sep; 361(1-2):78-86. PubMed ID: 18599227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of amiodarone on phospholipid content and composition in heart, lung, kidney and skeletal muscle: relationship to alteration of thyroid function.
    Rabkin SW
    Pharmacology; 2006; 76(3):129-35. PubMed ID: 16401913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic characteristics of amiodarone in long-term oral therapy in Japanese population.
    Kashima A; Funahashi M; Fukumoto K; Komamura K; Kamakura S; Kitakaze M; Ueno K
    Biol Pharm Bull; 2005 Oct; 28(10):1934-8. PubMed ID: 16204949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue distribution of amiodarone and desethylamiodarone in rats after multiple intraperitoneal administration of various amiodarone dosages.
    Plomp TA; Wiersinga WM; Maes RA
    Arzneimittelforschung; 1985; 35(1):122-9. PubMed ID: 4039141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redistribution of amiodarone in heart transplant recipients treated with the drug before operation.
    Nanas JN; Anastasiou-Nana MI; Margari ZJ; Karli J; Moulopoulos SD
    J Heart Lung Transplant; 1997 Apr; 16(4):387-9. PubMed ID: 9154947
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amiodarone concentrations in plasma and fat tissue during chronic treatment and related toxicity.
    Lafuente-Lafuente C; Alvarez JC; Leenhardt A; Mouly S; Extramiana F; Caulin C; Funck-Brentano C; Bergmann JF
    Br J Clin Pharmacol; 2009 May; 67(5):511-9. PubMed ID: 19552745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.